ArticleInternational journal of oncology2022
STAT5b is a marker of poor prognosis, rather than a therapeutic target in glioblastomas.
Nadège Dubois et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it